Indrayani Biotech Ltd.
BSE: 526445 | Sector: Services |
NSE: N.A. | ISIN Code: INE007C01021 |
BSE 00:00 | 10 Aug | 61.40 |
2.90 (4.96%) |
OPEN
60.35 |
HIGH
61.40 |
LOW
58.00 |
NSE 05:30 | 01 Jan | Indrayani Biotech Ltd Not listed in NSE |
OPEN | 60.35 |
PREVIOUS CLOSE | 58.50 |
VOLUME | 131108 |
52-Week high | 61.40 |
52-Week low | 13.26 |
P/E | 49.92 |
Mkt Cap.(Rs cr) | 210 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Indrayani Biotech Ltd.
Indrayani Biotech came out with a public issue in 1994 to part-finance its project to produce cut flowers strawberries tissue culture plantlets and hybrid vegetable seeds. The company also markets and distributes hybrid vegetable seeds manufactured by Hoechst India. It plans to produce these seeds for Hoechst in due course of time.Technical agreements have been signed with Floral Max Malaysia; for...> More
Indrayani Biotech Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
210 | |
EPS - TTM | (![]() |
[*S] | 1.23 |
P/E Ratio | (X) | [*S] | 49.92 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 7.06 |
P/B Ratio | (![]() |
[*S] | 8.70 |
Announcement
-
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015.
-
Statement Of Investor Complaints For The Quarter Ended June 2022
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
-
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations 2015.
-
Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements)Regulati
Indrayani Biotech Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 17.25 | 7.16 | 140.92 |
Other Income | 0.01 | 0.15 | -93.33 |
Total Income | 17.25 | 7.31 | 135.98 |
Total Expenses | 15.02 | 9.75 | 54.05 |
Operating Profit | 2.24 | -2.43 | 192.18 |
Net Profit | 1.61 | -3.25 | 149.54 |
Equity Capital | 34.23 | 34.23 | - |
Indrayani Biotech Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Benares Hotels | 2249.60 | -1.04 | 292.45 |
Asian Hotels (E) | 250.65 | 2.87 | 289.00 |
Sinclairs Hotels | 102.25 | 4.93 | 284.77 |
Indrayani Biotec | 61.40 | 4.96 | 210.17 |
The Byke Hospi. | 42.80 | 4.90 | 171.63 |
Asian Hotels (N) | 86.40 | -2.54 | 168.05 |
Kamat Hotels | 70.05 | 0.43 | 165.18 |
Indrayani Biotech Ltd - SHAREHOLDING PATTERN
|
|
Indrayani Biotech Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 6.69% | NA | 0.80% | 0.84% |
1 Month | 72.96% | NA | 7.96% | 8.10% |
3 Month | 105.01% | NA | 8.19% | 7.97% |
6 Month | 118.51% | NA | -0.18% | -0.40% |
1 Year | 292.58% | NA | 7.81% | 7.71% |
3 Year | NA | NA | 56.50% | 57.83% |
Indrayani Biotech Ltd - STOCK STRENGTH
Today's Low/High | 58.00 | 61.40 | |
Week Low/High | 53.65 | 61.40 | |
Month Low/High | 34.55 | 61.40 | |
YEAR Low/High | 13.26 | 61.40 | |
All TIME Low/High | 0.50 | 61.40 |
Quick Links for Indrayani Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices